Cartesian Therapeutics
RNAC
#6732
Rank
NZ$0.78 B
Marketcap
$32.97
Share price
3.61%
Change (1 day)
-40.08%
Change (1 year)

Cartesian Therapeutics (RNAC) Fails to deliver data

Key failure to deliver metrics for Cartesian Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Cartesian Therapeutics (RNAC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Cartesian Therapeutics (RNAC) - since 2016

Volume in USD (price x number of shares), data since 2016

Cartesian Therapeutics (RNAC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$0.52 M-58.7%
2023NZ$1.26 M35.2%
2022NZ$0.93 M-65.65%
2021NZ$2.71 M-98.97%
2020NZ$0.26 B19268.73%
2019NZ$1.36 M-89.59%
2018NZ$13.06 M194.21%
2017NZ$4.44 M-48.1%
2016NZ$8.55 M